Core Viewpoint - Enwei Pharmaceutical (301331.SZ) has signed a partnership agreement with several entities to invest in a venture capital fund, aiming to enhance its competitiveness and investment efficiency through collaboration with professional investment institutions [1] Investment Details - The company will invest RMB 20 million, accounting for 9.9502% of the fund's shares [1] - The partnership includes Shanghai Panlin Hongyu Enterprise Management Partnership and Tangshan Jinkun Chemical Co., Ltd. among others [1] Strategic Objectives - The investment aims to leverage the resources and advantages of professional investment institutions in the equity investment field [1] - The initiative is designed to control risks while pursuing investment opportunities in strategic emerging industries and future sectors that align with the company's long-term development [1]
恩威医药拟出资2000万元投资嘉兴磐霖嘉颐创业投资合伙企业